510(k) Report

FDA applicant

Casgarum Investment, S.L.

Illescas, ES1 decision2019–20190 recalls

FDA records 1 decision for Casgarum Investment, S.L. (Illescas, ES) in 2019: 1 510(k) clearance. All are in product code NGX (Stimulator, Muscle, Powered, For Muscle…). Its devices cite 2 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, physical medicine panel, where it files most

How often FDA has decided Casgarum Investment, S.L.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2019

2019: 1
2019high 1 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2019.

FIG. 1 — Casgarum Investment, S.L. by year, 2019–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Casgarum Investment, S.L.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • NGXStimulator, Muscle, Powered, For Muscle Conditioning1decision

Whose devices does it build on?

Its devices cite 2 predicates; 0 are its own earlier devices. The firms it cites most:

What has FDA decided for it lately?

  • K181419Flix-EmsCasgarum Investment, S.L. · 2019

The one decision as Casgarum Investment, S.L. →